Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A multicenter phase II study of eribulin monotherapy in patients with BRAF V600E mutant metastatic colorectal cancer

Trial Profile

A multicenter phase II study of eribulin monotherapy in patients with BRAF V600E mutant metastatic colorectal cancer

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 28 Sep 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Eribulin (Primary)
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Acronyms BRAVERY
  • Most Recent Events

    • 24 Sep 2021 Status changed from active, no longer recruiting to completed.
    • 17 Aug 2020 Planned End Date changed from 31 Dec 2019 to 18 Sep 2020.
    • 04 Jul 2020 Primary endpoint (Confirmed objective response rate(ORR) by investigators assessment) has not been met as per Results presented at the 22nd World Congress on Gastrointestinal Cancer.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top